Filing Impact
Filing Sentiment
Form Type
4
Genprex Inc
Aug 18, 2025
[8-K] Genprex, Inc. Reports Material Event
Aug 15, 2025
[8-K] Genprex, Inc. Reports Material Event
Aug 5, 2025
[RW] Genprex, Inc. SEC Filing
Aug 4, 2025
[8-K] Genprex, Inc. Reports Material Event
Jul 16, 2025
[DEF 14A] Genprex, Inc. Definitive Proxy Statement
7.10M
33.36M
0.33%
1.41%
2.49%
Biotechnology
Pharmaceutical Preparations
United States
AUSTIN